Now available on demand: This expert-led #CME program explores protoporphyrias, including EPP and XLP.
Hear clinicians discuss key symptoms, complications, and guideline-based management strategies.
Watch now โถ๏ธ bit.ly/4bVkVyb
#RareDiseaseCommunity #LivingWithEPP #LivingWithXLP #MedicalEducation
Posts by Medlive - A PlatformQ Health Brand
Today, we recognize the dedication, resilience, and impact of physicians everywhere. Thank you for everything you do to move patient care forward.
#NationalDoctorsDay #Healthcare #MedEd
#NationalDoctorsDay is almost here, and weโre celebrating you! We believe that continuous learning and collaboration are essential to advancing care. Physicians who register for Medlive by March 30 will be entered for a chance to receive a $100 FIGS Scrubs gift card: #[bit.ly/4daOw9j
Explore this #CME program on pediatric HoFH with expert insights on screening, diagnosis, and treatment to help prevent early cardiovascular disease.
โถ๏ธ Watch now: bit.ly/47Bz4za
#Cardiology #FamilialHypercholesterolemia #MedicalEducation
Now on demand: Expert insights on managing BCG-unresponsive #NMIBC and new bladder-sparing treatments.
Explore clinical strategies to help improve outcomes and preserve quality of life.
Watch now โก๏ธ bit.ly/4shPKUS
#Urology #BladderCancer #CME #NMIBC #MedicalEducation
Weโre excited to support our partner @nordrare.bsky.social's 2026 #NORDSymposium. Support rare disease research readiness, trial design, and progress for patients. Learn more here: nordscience.org
The Medlive team recently shared research at the #MDAconference with our poster on advancing clinician education in #BeckerMuscularDystrophy. Developed with @nordrare.bsky.social & MDA, this #CME initiative explores improving clinician awareness & preparedness for emerging therapies.
bit.ly/47u8LuJ
Management of high-risk NMIBC is evolving beyond BCG alone.
Get practical insights on immunotherapy plus BCG, including key clinical evidence and strategies for managing patients in everyday practice.
๐ Access the program: bit.ly/3MT4yKg
#NMIBC #BladderCancer #Urology
Weโre heading to #MDAconference to join the community advancing research, care, & education for #neuromuscular diseases & to connect with partners like @nordrare.bsky.social, GBS | CIDP, Blood Cancer United, & @aafanational.bsky.social
Stay tuned for details on our poster acceptance: bit.ly/4bca56N
A noteworthy highlight of #AAAAI26 was connecting with @aafanational.bsky.social ๐ As longtime collaborators, weโre proud to advance patient-centered education in #asthma & #allergy care together, delivering education that empowers patients & strengthens clinical decision-making. ๐ bit.ly/478yEQC
The team is onsite at #AAAAI26 this week & what an incredible few days itโs been connecting with APFED, I-FPIES, NEA, @faactnews.bsky.social, & others. ๐ Conversations centered on patient needs, education gaps, & elevating evidence-based resources for all. Explore our collaborations: bit.ly/3OIxu8c
For clinicians treating NMIBC, tolerability drives success with intravesical therapy.
Get practical tips to prevent early AEs, manage challenges, and improve procedural technique.
๐ Access the program: bit.ly/46CiLlk
#HCPEducation #NMIBC #BladderCancer #Urology #Oncology
Its Rare Disease Dayยฎ! Yesterday at #RDDNIH, we shared outcomes from our #CME initiative on #RettSyndrome. In partnership with @nordrare.bsky.social & @rettsyndrome.bsky.social, we highlighted how patient-centered education supports clinicians across diagnosis, treatment, & care. ๐ bit.ly/4snliIB
In the spirit of Rare Disease Day, save the date! Weโre excited to support our partner @nordrare.bsky.socialโs 2026 #NORDSymposium.
๐
April 14โ15, 2026 ๐ Arlington, VA
๐ Join us in advancing care for rare diseases: nordscience.org
Every person with a rare disease deserves access to the right care, research, and support. We are proud to stand with our partner @nordrare.bsky.social to expand access to rare disease education.
Join us to create a future where no condition is too rare to matter: bit.ly/4rA6FRZ ๐โจ๐ฆ
On-site at #GU26, sharing insights on advancing first-line care in locally advanced/metastatic #urothelial #carcinoma! Developed with partners LUGPA & @bladdercancerus.bsky.social, this initiative blends clinician & patient advocacy perspectives to drive community-informed education. bit.ly/4rHAgcw
Todayโs the day! Weโre at #RDDNIH spotlighting how advocacy partnerships shape real-world, patient-centered education in #RareDiseases. Partnering with @nordrare.bsky.social + @rettsyndrome.bsky.social, this CME initiative brings real patient experiences into case-based learning. ๐ bit.ly/4cen8Xp
Weโre heading to #AAAAI26 to join the global community advancing care in #asthma, #allergy, & #immunology. Excited to connect with leaders, researchers, & partners like @aafanational.bsky.social & @nordrare.bsky.social who are shaping the future of patient-centered education. See you in Philly! ๐
Weโre heading to #GU26 to share insights on advancing care in la/mUC. In collaboration with LUGPA & @bladdercancerus.bsky.social, this initiative brings clinician + patient advocacy voices into a community-informed education strategy. ๐ bit.ly/4rHlliy
@ascocancer.bsky.social
The average rare-disease patient waits years for a diagnosis, often seeing multiple specialists before receiving answers. Itโs time to change that.
Join the Rare Disease CME Challenge with @nordrare.bsky.social to get started: bit.ly/4kVUgph
We are proud to launch the first Earn Your Stripes: Rare Disease CME Challenge exclusively in partnership with @nordrare.bsky.social improve the early identification, diagnosis, and management of rare conditions. Start earning your stripes now: bit.ly/4rDTyQ4
Now on demand: This expert-led #CME program explores modern HoFH management, including emerging LDL-C therapies and practical strategies to optimize care.
Watch now: bit.ly/4cu703X
#HoFH #CardiologyCME #LDLCManagement #MedicalEducation
We're presenting outcomes at #GU26! Sharing new insights on advancing first-line care in la/mUC, our poster reflects a collaborative effort with LUGPA & @bladdercancerus.bsky.social, bringing together clinical & patient perspectives. Details soon: bit.ly/4kJhhvc
@ascocancer.bsky.social
Itโs been an energizing few days at #Alliance26, connecting with #CME partners and peers who are focused on measurable outcomes, scalable digital education, and patient-centered programming. To learn how Medlive supports outcomes-driven CME, visit ๐ tinyurl.com/42tw8cs5
@alliance4cehp.bsky.social
๐ Poster session highlights from #Alliance26 in Atlanta where we shared our outcomes poster, featuring learnings informed by a multi-year, multi-program educational initiative with @aafanational.bsky.social. Thank you to everyone who stopped by!
Read more: bit.ly/4c0r3H9
@alliance4cehp.bsky.social
Join our expert-led #CME program on HoFH management. Explore new LDL-C therapies and case-based care strategies.
Register now: bit.ly/4cu703X
#HoFH #CardiologyCME #LDLCManagement #MedicalEducation
Explore current evidence and best practices for advanced/metastatic NSCLC in this expert-led discussion, and earn #CME.
Watch now โก๏ธ bit.ly/3LMAI9K
#MedicalEducation #LungCancer #NSCLC #PrecisionOncology
We're heading to #RDDNIH to share outcomes from a #CME initiative on #RettSyndrome, highlighting patient-centered & outcomes-driven design to help close gaps in #RareDisease care. ๐
Stay tuned for poster details & explore rare disease programs here: bit.ly/3Mq3SM3
@nordrare.bsky.social & IRSF
Throwback to 1970 or #Alliance25? ๐ ๐บ Excited to share that we'll be back at #Alliance26, sharing learnings from a multi-year, multi-program outcomes assessment across clinician + patient education. Read more: ๐ bit.ly/4rzMVNY
@alliance4cehp.bsky.social @aafanational.bsky.social
Only ~20% of eligible patients receive CAR T therapy. Access shouldnโt depend on zip code. On #WorldCancerDay, take steps toward change for community-based care expansion.
Act now by watching the full CME program with our partners @aacicancer.bsky.social & @astct.bsky.social ๐ bit.ly/3Zx8Jhd